PA2.26 antigen (T1a/podoplanin): A small mucin-like transmembrane glycoprotein associated with cell migration and cancer

Clinical and Translational Oncology

Volumn 5, Issue 9, 2003, Pages 491-499

  Villar, Ester Martín ^a   Scholl, Francisco Gómez ^a,c   Amat, Carlos Gamallo ^b   Avila, Miguel Quintanilla ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c Center for Neurobiology and Behavior ^*  (United States)

Author keywords

Cell migration; Lymphatic endothelium; Metastasis; Mucin; PA226; Podoplanin; T1a

Indexed keywords

EID: 84873437329     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Gendler SJ, Spicer AP. Epithelial mucin genes. Annu Rev Physiol 1995;57:607-34.
2. Hilkens J, Ligtenberg MJL, Vos HL, et al. Cell membrane-associated mucins and their adhesion-modulating properties. Trends Biochem Sci 1992;17:359-63.
3. Carraway KL, Ramsauer VP, Haq B, et al. Cell signaling through membrane mucins. BioEssays 2002;25:66-71.
4. Wesseling J, van der Valk SW, Vos HL, et al. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995;129:255-65.
5. Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane associated mucin episialin/MUC1. Mol Biol Cell 1996;7:565-77.
6. Zhang K, Baeckstrom D, Brevinge H, et al. Comparison of sialyl-Lewis a-carrying CD43 and MUC1 mucin secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion. Tumor Biol 1997;18:175-87.
7. Zhang K, Baeckstrom D, Brevinge H, et al. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte to E-selectin-expressing endothelial cells. J Cell Biochem 1996;60:538-49.
8. Yamamoto M, Bharti A, Ly I, et al. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and b-catenin in cell adhesion. J Biol Chem 1997;272:12492-4.
9. Ben-Ze'ev A, Shtutman M, Zhurinsky J. The integration of cell adhesion with gene expression: The role of b-catenin. Exp Cell Res 2000;261:75-82.
10. Komatsu M, Carraway CAC, Fregien NL, et al. Reversible disruption of cell-matrix and cell-cell interaction by overexpression of sialomucin complex. J Biol Chem 1997;272:33245-54.
11. Jepson S, Komatsu M, Haq B, et al. Muc4/sialomucin complex, the intramembrane ErbB2 ligan, induces specific phosphorylation of ErbB2 and enhances expression of p27 (kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways. Oncogene 2002; 21:7524-32.
12. Varki A. Selectin ligands. Proc Natl Acad Sci USA 1994; 91:7390-7.
13. Shimizu Y, Shaw S. Mucins in the mainstream. Nature 1993;366:630-1.
14. Gandarillas A, Scholl FG, Benito N, et al. Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis. Mol Carcinog 1997;20:10-8.
15. Scholl FG, Gamallo C, Vilaró S, et al. Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. J Cell Sci 1999;112: 4601-13.
16. Yonemura S, Hirao M, Doi Y, et al. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 1998;140:885-95.
17. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 2002;3:586-99.
18. Ino Y, Gotoh M, Sakamoto M, et al. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA 2002;99:365-70.
19. Nose K, Saito H, Kuroki T. Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells. Cell Growth Differ 1990;1:511-8.
20. Farr AG, Berry ML, Kim A, et al. Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues. J Exp Med 1992;176:1477-82.
21. Wetterwald A, Hoffstetter W, Cecchini MG, et al. Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone 1996;18: 25-132.
22. Rishi AK, Joyce-Brady M, Fisher J, et al. Cloning, characterization, and development expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives. Dev Biol 1995;167:294-306.
23. Gonzalez RF, Dobbs LG. Purification and analysis of RT140, a type I alveolar epithelial cell apical membrane protein. Biochim Biophys Acta 1998;1429:208-16.
24. Breiteneder-Geleff S, Matsui, K, Soleiman A, et al. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 1997;151:1141-52.
25. Zimmer G, Klenk H-D, Herrler G. Identification of a 40-kda cell surface sialoglycoprotein with the characteristics of a major influenza C virus receptor in a Madin-Darby canine kidney cell line. J Biol Chem 1995;270: 17815-22.
26. Zimmer G, Oefner F, von Messling V, et al. Cloning and characterization of gp36, a human mucin-type glycoprotein preferentially expressed in vascular endothelium. Biochem J 1999;341:277-84.
27. Ma T, Yang B, Matthay MA, et al. Evidence against a role of mouse, rat, and two cloned human T1a isoforms as a water channel or a regulator of aquoporin-type water channels. Am J Respir Cell Mol Biol 1998;19: 143-9.
28. Kriehuber E, Breiteneder-Geleff S, Groeger M, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 2001;194: 797-808.
29. Williams MC, Cao YX, Hinds A, et al. T1a protein is developmentally regulated and expressed by alveolar type I cells, chroid plexus, and ciliary epithelia of adult rats. Am J Respir Cell Mol Biol 1996;14:577-85.
30. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries. Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999;154:385-94.
31. Ramirez MI, Millien G, Hinds A, et al. T1a, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev Biol 2003;256:61-72.
32. Schacht V, Ramírez MI, Hong Y-K, et al. T1a/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 2003;22:3546-56.
33. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999;98:769-78.
34. Oliver G, Detmar M. The rediscovery of the lymphatic system. Old and new insights into the development and biological function of lymphatic vascular system. Genes Dev 2002;16:773-83.
35. Petrova TV, Mäkinen T, Mäkelä T, et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 2002;17:4593-9.
36. Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002;21:1505-13.
37. Hong Y-K, Harvey N, Noh Y-H, et al. Prox1 is a master control gene in the program specifying lymphatic endothelial fate. Dev Dyn 2002;225:351-7.
38. Swartz MA, Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Microsc Res Techniq 2001;55: 92-9.
39. Karpanen T, Alitalo K. Lymphatic vessels as targets of tumor therapy? J Exp Med 2001;194: F37-42.
40. Stacker SA, Achen MG, Jussila L, et al. Lymphangiogenesis and cancer metastasis. Nature Rev Cancer 2002;2: 573-83.
41. Pepper MS. Lymphangiogenesis and tumor metastasis: Mith or reality? Clin Cancer Res 2001;7: 462-8.
42. Sleeman JP, Krishnan J, Kirkin V, et al. Markers of the lymphatic endothelium: In search of the holy grail? Microsc Res Techniq 2001;55: 61-9.
43. Birner P, Shindl M, Obermair A, et al. Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis. Anticancer Res 2000;20:2981-5.
44. Muñoz-Guerra MF, Marazuela EG, Martín-Villar E, et al. Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity: A study of the early stages [in press]. Cance.r.
45. Aoki S, Shimamura T, Shibata T, et al. Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br J Cancer 2003;88:726-32.
46. Shimamura T, Sakamoto N, Ino Y, et al. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness. Relationship to E-cadherin expression. J Clin Oncol 2003;21:659-67.
47. Bissell MJ, Radisky D. Putting tumors in context. Nature Rev Cancer 2001;1:46-54.
48. Takahashi K, Sasaki T, Mammoto A, et al. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/ radixin/moesin initiates the activation of the Rho small G protein. J Biol Chem 1997;272:23371-5.
49. Berryman M, Franck Z, Bretscher A. Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 1993;105:1025-43.
50. Amieva MR, Wigenbus KK, Furthmayr H. Radixin is a component of hepatocyte microvilli in situ. Exp Cell Res 1994;210:140-4.
51. Scholl FG, Gamallo C, Quintanilla M. Ectopic expression of PA2.26 antigen in epidermal keratinocytes leads to destabilization of adherens junctions and malignant progression. Lab Invest 2000;80:1749-59.
52. Angata T, Brinkman-Van der Linden ECM. I-type lectins. Biochim Biophys Acta 2002;1572:294-316.
53. Boucherot K, Schreiber R, Pavenstadt H, et al. Cloning and expression of the mouse glomerular podoplanin homologue gp38p. Nephrol Dial Transplant 2002;17:978-84.
54. Taniguchi K, Harada N, Ohizumi I, et al. Molecular cloning and characterization of antigens expressed on rat tumor vascular endothelial cells. Int J Cancer 2000;86: 799-805.